The ACTL6A gene is frequently amplified in cancers, such as lung and ovarian cancer, and ACTL6A overexpression has been linked to an earlier relapse rate in ovarian and lung cancer patients who received cisplatin therapy. Here, ACTL6A is linked to ovarian carcinoma.